US4077407A
(en)
*
|
1975-11-24 |
1978-03-07 |
Alza Corporation |
Osmotic devices having composite walls
|
US4445885A
(en)
*
|
1977-02-16 |
1984-05-01 |
Unitika, Ltd. |
Insulin releasing supplier
|
US4519909A
(en)
*
|
1977-07-11 |
1985-05-28 |
Akzona Incorporated |
Microporous products
|
US4159720A
(en)
*
|
1977-11-28 |
1979-07-03 |
Burton Andrew F |
Infusion of liquids into tissue
|
US4304672A
(en)
*
|
1978-04-04 |
1981-12-08 |
Sbr Lab, Inc. |
Stored blood and liquid system pH control method and apparatus
|
NZ192673A
(en)
*
|
1979-02-02 |
1984-07-06 |
Merck & Co Inc |
Ophthalmic compositions for lowering intraocular pressure
|
US4235236A
(en)
*
|
1979-02-12 |
1980-11-25 |
Alza Corporation |
Device for dispensing drug by combined diffusional and osmotic operations
|
US4357236A
(en)
*
|
1979-05-17 |
1982-11-02 |
Borg-Warner Corporation |
Automatic addition of a corrosion inhibitor to a coolant system by osmotic pressure
|
ATE9059T1
(de)
*
|
1980-01-28 |
1984-09-15 |
Merck & Co. Inc. |
Ophthalmische kohlensaure anhydrase-inhibitoren enthaltende einlagen zur verringerung intraokularer hypertension.
|
IE50901B1
(en)
*
|
1980-03-04 |
1986-08-06 |
Merck & Co Inc |
Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
|
JPS57140710A
(en)
*
|
1981-02-24 |
1982-08-31 |
Shionogi & Co Ltd |
Capsule agent for rectal administration
|
WO1982000096A1
(en)
*
|
1980-07-09 |
1982-01-21 |
Maren T |
Process for reducing intraocular pressure
|
US4300558A
(en)
*
|
1980-07-18 |
1981-11-17 |
Alza Corporation |
Self-driven fluid dispenser
|
US4439195A
(en)
*
|
1980-10-14 |
1984-03-27 |
Alza Corporation |
Theophylline therapy
|
US4364385A
(en)
*
|
1981-03-13 |
1982-12-21 |
Lossef Steven V |
Insulin delivery device
|
US4484921A
(en)
*
|
1982-02-01 |
1984-11-27 |
Alza Corporation |
Theophylline therapy utilizing osmotic delivery
|
JPS5931701A
(ja)
*
|
1982-08-16 |
1984-02-20 |
Nitto Electric Ind Co Ltd |
液状活性物質含有膜及びその製造方法
|
US4443428A
(en)
*
|
1982-06-21 |
1984-04-17 |
Euroceltique, S.A. |
Extended action controlled release compositions
|
US4478596A
(en)
*
|
1982-11-26 |
1984-10-23 |
Michelson Paul E |
Delivery system for physiologically active agents
|
US4613330A
(en)
*
|
1982-11-26 |
1986-09-23 |
Michelson Paul E |
Delivery system for desired agents
|
IE53703B1
(en)
*
|
1982-12-13 |
1989-01-18 |
Elan Corp Plc |
Drug delivery device
|
US4722937A
(en)
*
|
1984-06-29 |
1988-02-02 |
Joseph Jacob |
Antitoxin vaginal products and catamenials
|
US4585792A
(en)
*
|
1983-05-05 |
1986-04-29 |
Technology Unlimited Inc. |
Protective additive to vaginal products and catamenials
|
US4722936A
(en)
*
|
1983-05-05 |
1988-02-02 |
Joseph Jacob |
Deodorization vaginal products and catamenials
|
US4765989A
(en)
*
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US5082668A
(en)
*
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
US4783337A
(en)
*
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
US4503030A
(en)
*
|
1983-06-06 |
1985-03-05 |
Alza Corporation |
Device for delivering drug to certain pH environments
|
US4627850A
(en)
*
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
US4751071A
(en)
*
|
1983-12-01 |
1988-06-14 |
Alza Corporation |
Composition comprising salbutamol
|
US4851229A
(en)
*
|
1983-12-01 |
1989-07-25 |
Alza Corporation |
Composition comprising a therapeutic agent and a modulating agent
|
US4777049A
(en)
*
|
1983-12-01 |
1988-10-11 |
Alza Corporation |
Constant release system with pulsed release
|
GB2150830B
(en)
*
|
1983-12-05 |
1987-08-19 |
Alza Corp |
Drug dispenser
|
US4761159A
(en)
*
|
1984-01-23 |
1988-08-02 |
Lewis Knox |
Method of chemical deodorization of articles and solutions used in medical and biological procedures
|
US4729793A
(en)
*
|
1985-08-09 |
1988-03-08 |
Alza Corporation |
Composition for manufacturing wall of dispensing device
|
US4663149A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising inner and outer walls functioning as cooperative unit
|
US4716031A
(en)
*
|
1984-03-21 |
1987-12-29 |
Alza Corporation |
Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
|
US4692326A
(en)
*
|
1984-03-21 |
1987-09-08 |
Alza Corporation |
Dispenser comprising inner positioned soft or hard capsule
|
US4663148A
(en)
*
|
1984-03-21 |
1987-05-05 |
Alza Corporation |
Dispenser comprising telescopically engaging members
|
US4800056A
(en)
*
|
1984-03-21 |
1989-01-24 |
Alza Corporation |
Process for making dispenser with cooperating elements
|
US4814180A
(en)
*
|
1984-03-21 |
1989-03-21 |
Alza Corporation |
Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
|
US4615698A
(en)
*
|
1984-03-23 |
1986-10-07 |
Alza Corporation |
Total agent osmotic delivery system
|
US4649075A
(en)
*
|
1984-08-09 |
1987-03-10 |
Leonora Jost |
Transdermal and transmucosal vortexed foam devices and the method of making
|
US4743247A
(en)
*
|
1984-08-13 |
1988-05-10 |
Alza Corporation |
Process for manufacturing dosage form
|
GB8422876D0
(en)
*
|
1984-09-11 |
1984-10-17 |
Secr Defence |
Silicon implant devices
|
US4693886A
(en)
*
|
1985-04-22 |
1987-09-15 |
Alza Corporation |
Osmotic device with inert core
|
US4609374A
(en)
*
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
US4655766A
(en)
*
|
1985-08-01 |
1987-04-07 |
Alza Corporation |
Fluid imbibing pump with self-regulating skin patch
|
US4756314A
(en)
*
|
1985-10-28 |
1988-07-12 |
Alza Corporation |
Sweat collection patch
|
AU592629B2
(en)
*
|
1986-01-31 |
1990-01-18 |
Whitby Research, Inc. |
Compositions comprising 1-substituted azacycloalkanes and their uses
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
US4867969A
(en)
*
|
1986-02-07 |
1989-09-19 |
Alza Corporation |
Hydrogel formulation for administering non-steroidal drugs
|
US4747847A
(en)
*
|
1986-02-07 |
1988-05-31 |
Alza Corporation |
System for delivering potassium chloride with enhanced bioacceptability
|
US4971790A
(en)
*
|
1986-02-07 |
1990-11-20 |
Alza Corporation |
Dosage form for lessening irritation of mocusa
|
US4786500A
(en)
*
|
1986-06-26 |
1988-11-22 |
Alza Corporation |
Programmable agent delivery system
|
US4927632A
(en)
*
|
1986-06-26 |
1990-05-22 |
Alza Corporation |
Selective pulsed drug delivery system
|
US4885868A
(en)
*
|
1986-12-03 |
1989-12-12 |
Cornell Research Foundation, Inc. |
Banding techniques for plant propagation
|
US4917688A
(en)
*
|
1987-01-14 |
1990-04-17 |
Nelson Research & Development Co. |
Bandage for transdermal delivery of systemically-active drug
|
US4832690A
(en)
*
|
1987-01-23 |
1989-05-23 |
Baxter International Inc. |
Needle-pierceable cartridge for drug delivery
|
US4801461A
(en)
*
|
1987-01-28 |
1989-01-31 |
Alza Corporation |
Pseudoephedrine dosage form
|
US5023076A
(en)
*
|
1987-02-27 |
1991-06-11 |
Alza Corporation |
Lamina comprising carboxyvinyl polymer
|
US4915952A
(en)
*
|
1987-02-27 |
1990-04-10 |
Alza Corporation |
Composition comprising drug, HPC, HPMC and PEO
|
US4731122A
(en)
*
|
1987-03-30 |
1988-03-15 |
Alza Corporation |
Process for manufacturing a thermoplastic molding composition
|
US5340590A
(en)
*
|
1987-06-25 |
1994-08-23 |
Alza Corporation |
Delivery system with bilayer osmotic engine
|
US5236689A
(en)
*
|
1987-06-25 |
1993-08-17 |
Alza Corporation |
Multi-unit delivery system
|
US5391381A
(en)
*
|
1987-06-25 |
1995-02-21 |
Alza Corporation |
Dispenser capable of delivering plurality of drug units
|
US4795641A
(en)
*
|
1987-08-20 |
1989-01-03 |
Eastman Kodak Company |
Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
US4877618A
(en)
*
|
1988-03-18 |
1989-10-31 |
Reed Jr Fred D |
Transdermal drug delivery device
|
US4855141A
(en)
*
|
1988-03-25 |
1989-08-08 |
Alza Corporation |
Device comprising means for protecting and dispensing fluid sensitive medicament
|
US4959218A
(en)
*
|
1988-03-25 |
1990-09-25 |
Alza Corporation |
Method for delivering somatotropin to an animal
|
US4996060A
(en)
*
|
1988-03-25 |
1991-02-26 |
Alza Corporation |
Device comprising liner for protecting fluid sensitive medicament
|
US5024842A
(en)
*
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5160743A
(en)
*
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
US5006346A
(en)
*
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
GB8820353D0
(en)
*
|
1988-08-26 |
1988-09-28 |
Staniforth J N |
Controlled release tablet
|
US5612059A
(en)
*
|
1988-08-30 |
1997-03-18 |
Pfizer Inc. |
Use of asymmetric membranes in delivery devices
|
US5110596A
(en)
*
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
US5135523A
(en)
*
|
1988-12-13 |
1992-08-04 |
Alza Corporation |
Delivery system for administering agent to ruminants and swine
|
US5037420A
(en)
*
|
1988-12-13 |
1991-08-06 |
Alza Corporation |
Delivery system comprising two sections for delivering somatotropin
|
US5174999A
(en)
*
|
1988-12-13 |
1992-12-29 |
Alza Corporation |
Delivery system comprising fluid ingress and drug egress
|
US5059423A
(en)
*
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
US5728088A
(en)
*
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
US5057318A
(en)
*
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
IL92966A
(en)
*
|
1989-01-12 |
1995-07-31 |
Pfizer |
Hydrogel-operated release devices
|
US5030452A
(en)
*
|
1989-01-12 |
1991-07-09 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
US5019396A
(en)
*
|
1989-05-12 |
1991-05-28 |
Alza Corporation |
Delivery dispenser for treating cardiac arrhythmias
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
US5126142A
(en)
*
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
US6361795B1
(en)
*
|
1989-09-05 |
2002-03-26 |
Alza Corporation |
Method for lowering blood glucose
|
US5035897A
(en)
*
|
1989-09-05 |
1991-07-30 |
Alza Corporation |
Dosage form for delivering soluble or insoluble drugs
|
US5112614A
(en)
*
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
US5098714A
(en)
*
|
1989-11-16 |
1992-03-24 |
Alza Corporation |
Osmotic, oral dosage form for fertility control
|
US5200197A
(en)
*
|
1989-11-16 |
1993-04-06 |
Alza Corporation |
Contraceptive pill
|
US5474785A
(en)
*
|
1990-01-24 |
1995-12-12 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
US5223266A
(en)
*
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
US5221536A
(en)
*
|
1990-05-07 |
1993-06-22 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
US5190763A
(en)
*
|
1990-05-07 |
1993-03-02 |
Alza Corporation |
Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
|
US5192550A
(en)
*
|
1990-05-07 |
1993-03-09 |
Alza Corporation |
Dosage form for treating central nervous system disorders
|
US5234692A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5180591A
(en)
*
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5238687A
(en)
*
|
1990-07-11 |
1993-08-24 |
Alza Corporation |
Delivery device with a protective sleeve
|
US5234694A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Method for increasing feed efficiency in animals
|
US5234693A
(en)
*
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
EP0542926B1
(en)
*
|
1990-08-07 |
1995-02-15 |
Pfizer Inc. |
Use of interfacially-polymerized membranes in delivery devices
|
JP2701977B2
(ja)
*
|
1990-09-28 |
1998-01-21 |
ファイザー インク |
疎水性媒体を含有する投薬体
|
US5378475A
(en)
*
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
US6764697B1
(en)
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
US5178867A
(en)
*
|
1991-08-19 |
1993-01-12 |
Alza Corporation |
Dosage form for delivering drug in short-time period
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
US5200195A
(en)
*
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
US5254349A
(en)
*
|
1991-12-06 |
1993-10-19 |
Alza Corporation |
Process for lessening irritation caused by drug
|
US5266332A
(en)
*
|
1991-12-06 |
1993-11-30 |
Alza Corporation |
Method for administering anti-Parkinson drug
|
US5200194A
(en)
*
|
1991-12-18 |
1993-04-06 |
Alza Corporation |
Oral osmotic device
|
IT1255522B
(it)
*
|
1992-09-24 |
1995-11-09 |
Ubaldo Conte |
Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
|
US5358721A
(en)
*
|
1992-12-04 |
1994-10-25 |
Alza Corporation |
Antiviral therapy
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
*
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US20060263428A1
(en)
*
|
1993-09-20 |
2006-11-23 |
Eugenio Cefali |
Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US20080045573A1
(en)
*
|
1993-09-20 |
2008-02-21 |
Bova David J |
Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia
|
US6129930A
(en)
*
|
1993-09-20 |
2000-10-10 |
Bova; David J. |
Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
|
US6080428A
(en)
*
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6183778B1
(en)
|
1993-09-21 |
2001-02-06 |
Jagotec Ag |
Pharmaceutical tablet capable of liberating one or more drugs at different release rates
|
US5532003A
(en)
*
|
1994-01-18 |
1996-07-02 |
Alza Corporation |
Pentoxifylline therapy
|
US5773021A
(en)
*
|
1994-03-14 |
1998-06-30 |
Vetoquinol S.A. |
Bioadhesive ophthalmic insert
|
US5525279A
(en)
*
|
1994-04-04 |
1996-06-11 |
Sekisui Kagaku Kogyo K.K. |
Method of forming a granulocyte adsorbing carrier and granulocyte remover
|
ZA953078B
(en)
*
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
US5698224A
(en)
*
|
1994-06-27 |
1997-12-16 |
Alza Corporation |
Tacrine therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US5595759A
(en)
*
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
US5690952A
(en)
*
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
US5713852A
(en)
*
|
1995-06-07 |
1998-02-03 |
Alza Corporation |
Oral dosage and method for treating painful conditions of the oral cavity
|
IT1282576B1
(it)
|
1996-02-06 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
IT1282650B1
(it)
*
|
1996-02-19 |
1998-03-31 |
Jagotec Ag |
Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
ZA975326B
(en)
|
1996-06-18 |
1998-01-14 |
Alza Corp |
Device and method for enhancing transdermal flux of agents being delivered or sampled.
|
US5800624A
(en)
*
|
1996-10-22 |
1998-09-01 |
University Of Notre Dame |
Membrane process for separating carbohydrates
|
WO1998018452A1
(en)
*
|
1996-10-25 |
1998-05-07 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6361796B1
(en)
|
1996-10-25 |
2002-03-26 |
Shire Laboratories, Inc. |
Soluble form osmotic dose delivery system
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US5902598A
(en)
*
|
1997-08-28 |
1999-05-11 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices
|
US6514530B2
(en)
|
1997-09-09 |
2003-02-04 |
Alza Corporation |
Dosage form comprising means for changing drug delivery shape
|
IN186245B
(nl)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
US20040062799A1
(en)
*
|
1997-09-29 |
2004-04-01 |
Ayer Atul D. |
Therapeutic composition and delivery system for administering drug
|
AU1534699A
(en)
|
1997-12-05 |
1999-06-28 |
Alza Corporation |
Osmotic dosage form comprising first and second coats
|
ES2412409T3
(es)
|
1997-12-22 |
2013-07-11 |
Euro-Celtique S.A. |
Forma farmacéutica para dosificación oral que comprende una combinación de un agonista opiáceo y un antagonista opiáceo
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
JP2001526229A
(ja)
*
|
1997-12-22 |
2001-12-18 |
ユーロ−セルティーク,エス.エイ. |
オピオイド投薬剤形の乱用を防止する方法
|
CN100388916C
(zh)
*
|
1997-12-22 |
2008-05-21 |
阿尔扎有限公司 |
用于控释药物传递装置的速率控制膜
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6099859A
(en)
*
|
1998-03-20 |
2000-08-08 |
Andrx Pharmaceuticals, Inc. |
Controlled release oral tablet having a unitary core
|
US20010038855A1
(en)
*
|
1998-06-05 |
2001-11-08 |
Desjardin Michael A. |
Dosage form for administering prescribed dose
|
US6099862A
(en)
|
1998-08-31 |
2000-08-08 |
Andrx Corporation |
Oral dosage form for the controlled release of a biguanide and sulfonylurea
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
US6174547B1
(en)
*
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
GB9822854D0
(en)
|
1998-10-21 |
1998-12-16 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
JP2002528486A
(ja)
|
1998-11-02 |
2002-09-03 |
アルザ・コーポレーション |
有効物質の送達制御
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
EP1152709B1
(en)
*
|
1999-02-02 |
2005-01-12 |
Wright Medical Technology, Inc. |
Controlled release composite
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
US6319510B1
(en)
|
1999-04-20 |
2001-11-20 |
Alayne Yates |
Gum pad for delivery of medication to mucosal tissues
|
US6387403B1
(en)
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
JP2003516345A
(ja)
*
|
1999-12-09 |
2003-05-13 |
アルザ・コーポレーション |
抗ウイルス剤
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
WO2002036099A1
(en)
|
2000-10-30 |
2002-05-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US6866866B1
(en)
*
|
2000-11-03 |
2005-03-15 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6790459B1
(en)
|
2000-11-03 |
2004-09-14 |
Andrx Labs, Llc |
Methods for treating diabetes via administration of controlled release metformin
|
KR20030061392A
(ko)
|
2000-11-03 |
2003-07-18 |
안드렉스 코포레이션 |
방출 조절성 메트포민 조성물
|
US20060034922A1
(en)
*
|
2000-11-03 |
2006-02-16 |
Andrx Labs, Llc |
Controlled release metformin compositions
|
US6632217B2
(en)
*
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
ATE502657T1
(de)
|
2001-05-01 |
2011-04-15 |
Av Topchiev Inst Petrochemical |
Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
|
CA2445086C
(en)
|
2001-05-01 |
2008-04-08 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
CA2446550C
(en)
|
2001-05-11 |
2012-03-06 |
Endo Pharmaceuticals, Inc. |
Abuse-resistant controlled-release opioid dosage form
|
WO2002100318A2
(en)
|
2001-06-12 |
2002-12-19 |
Johns Hopkins University School Of Medicine |
Reservoir device for intraocular drug delivery
|
WO2003007802A2
(en)
|
2001-07-18 |
2003-01-30 |
Euro-Celtique, S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
WO2003013433A2
(en)
*
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
WO2003026625A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Modified release dosage forms
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
EP1492509A1
(en)
*
|
2001-12-18 |
2005-01-05 |
ALZA Corporation |
Dosage form providing time-varying patterns of drug delivery
|
NZ533062A
(en)
*
|
2001-12-19 |
2006-03-31 |
Alza Corp |
Formulation and dosage form for the controlled delivery of therapeutic agents
|
WO2003053401A2
(en)
*
|
2001-12-19 |
2003-07-03 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
US20030161882A1
(en)
*
|
2002-02-01 |
2003-08-28 |
Waterman Kenneth C. |
Osmotic delivery system
|
US20030175346A1
(en)
*
|
2002-02-01 |
2003-09-18 |
Anne Billotte |
Osmotic delivery system
|
US7004171B2
(en)
*
|
2002-02-25 |
2006-02-28 |
Hi-Gienic Intra Vaginal Technologies Ltd. |
System for transvaginal drug delivery
|
ITMI20020515A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema per il rilasco controllato di uno o piu' principi attivi
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
CA2708900C
(en)
*
|
2002-04-05 |
2019-06-04 |
Purdue Pharma |
Pharmaceutical preparation containing oxycodone and naloxone
|
AU2003234216A1
(en)
*
|
2002-04-29 |
2003-11-17 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
US8871241B2
(en)
*
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US20040052848A1
(en)
*
|
2002-05-23 |
2004-03-18 |
Xiu-Xiu Cheng |
Biguanide formulations
|
US20030224045A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Chien-Hsuan Han |
Combination immediate release sustained release levodopa/carbidopa dosage forms
|
US20060013875A1
(en)
*
|
2002-05-29 |
2006-01-19 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US7094427B2
(en)
*
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
RU2004134728A
(ru)
*
|
2002-05-31 |
2005-06-10 |
Алза Корпорейшн (Us) |
Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
AU2003245738A1
(en)
*
|
2002-06-28 |
2004-01-19 |
Alza Corporation C/O Johnson & Johnson |
Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition
|
JP2005536568A
(ja)
*
|
2002-07-29 |
2005-12-02 |
アルザ・コーポレーシヨン |
トピラメートの調節分配用の調剤および投薬形態
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
AU2003272504A1
(en)
|
2002-09-20 |
2004-04-08 |
Andrx Labs Llc |
Multistage formulation containing a biguanide and thiazolidindione derivatives
|
US20050048119A1
(en)
*
|
2002-09-20 |
2005-03-03 |
Avinash Nangia |
Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
|
US7959946B2
(en)
|
2002-09-20 |
2011-06-14 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
US7785627B2
(en)
*
|
2002-09-20 |
2010-08-31 |
Watson Pharmaceuticals, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
US9060941B2
(en)
*
|
2002-09-20 |
2015-06-23 |
Actavis, Inc. |
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
|
AR041744A1
(es)
*
|
2002-10-31 |
2005-05-26 |
Alza Corp |
Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida
|
WO2004041246A1
(en)
*
|
2002-10-31 |
2004-05-21 |
Alza Corporation |
Pharmaceutical formulation providing an increased biovailability of hydrophobic drugs
|
US6893660B2
(en)
*
|
2002-11-21 |
2005-05-17 |
Andrx Pharmaceuticals, Inc. |
Stable pharmaceutical compositions without a stabilizer
|
WO2004054542A2
(en)
|
2002-12-13 |
2004-07-01 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
EP1572190B1
(en)
*
|
2002-12-17 |
2007-04-18 |
Abbott GmbH & Co. KG |
Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
|
US7259186B2
(en)
*
|
2002-12-17 |
2007-08-21 |
Abbott Laboratories |
Salts of fenofibric acid and pharmaceutical formulations thereof
|
US20080051411A1
(en)
*
|
2002-12-17 |
2008-02-28 |
Cink Russell D |
Salts of Fenofibric Acid and Pharmaceutical Formulations Thereof
|
KR20050095835A
(ko)
*
|
2003-01-14 |
2005-10-04 |
알자 코포레이션 |
조정된 점성층을 갖는 방법 및 제형
|
CA2515641A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
US7611480B2
(en)
*
|
2003-04-24 |
2009-11-03 |
Levy Mark M |
Gastrointestinal bioreactor
|
US20070259014A1
(en)
*
|
2003-06-20 |
2007-11-08 |
Vgx Pharmaceuticals, Inc. |
Compositions for and Methods for Treating Hiv
|
CA2530113C
(en)
*
|
2003-06-26 |
2013-08-13 |
Control Delivery Systems, Inc. |
Bioerodible sustained release drug delivery systems
|
EP2112920B1
(en)
|
2003-06-26 |
2018-07-25 |
Intellipharmaceutics Corp. |
Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
|
CN101862455A
(zh)
|
2003-06-26 |
2010-10-20 |
普西维达公司 |
原位胶凝的药物递送系统
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
EP1701697A2
(en)
*
|
2003-09-02 |
2006-09-20 |
ALZA Corporation |
Novel drug compositions and dosage forms of topiramate
|
US7611728B2
(en)
*
|
2003-09-05 |
2009-11-03 |
Supernus Pharmaceuticals, Inc. |
Osmotic delivery of therapeutic compounds by solubility enhancement
|
EP2298303A1
(en)
|
2003-09-25 |
2011-03-23 |
Euro-Celtique S.A. |
Pharmaceutical combinations of hydrocodone and naltrexone
|
DE602004006763T2
(de)
*
|
2003-09-26 |
2008-02-07 |
Alza Corp., Mountain View |
Darreichungsform zur kontrollierten Freisetzung einer Formulierung mit aktivem Mittel und Verfahren zur Herstellung der Darreichungsform
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
JP2007524652A
(ja)
*
|
2003-09-26 |
2007-08-30 |
アルザ・コーポレーシヨン |
アルプラゾラムの制御送達のための浸透性投薬形態物
|
KR20060070575A
(ko)
*
|
2003-09-26 |
2006-06-23 |
알자 코포레이션 |
활성성분 제제의 방출제어용 제형
|
DE602004032149D1
(de)
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
ATE544447T1
(de)
*
|
2003-09-26 |
2012-02-15 |
Alza Corp |
Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
|
AU2004275835B2
(en)
|
2003-09-26 |
2011-06-23 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
AU2004285532A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Administration of levodopa and carbidopa
|
US20050095288A1
(en)
*
|
2003-11-03 |
2005-05-05 |
Andrx Labs, Llc |
Decongestant and expectorant tablets
|
WO2005048981A1
(en)
*
|
2003-11-14 |
2005-06-02 |
Alza Corporation |
Controlled release of topirimate in liquid dosage forms
|
WO2005051325A2
(en)
*
|
2003-11-25 |
2005-06-09 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol compositions methods of treatment and delivery
|
JP5072364B2
(ja)
*
|
2003-11-25 |
2012-11-14 |
スミスクライン ビーチャム (コーク) リミテッド |
カルベジロール遊離塩基、カルベジロール塩、無水形態またはその溶媒和物、対応する医薬組成物、制御放出処方および治療またはデリバリー方法
|
US20050129764A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Vergez Juan A. |
Osmotic device containing licofelone
|
CA2550866A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
CA2551815A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation |
Novel drug compositions and dosage forms
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
RU2380092C2
(ru)
|
2004-01-30 |
2010-01-27 |
Кориум Интернэшнл, Инк. |
Быстро растворяющаяся пленка для доставки активного агента
|
US20050196447A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196442A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
US20050196448A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Hai Yong Huang |
Polymeric compositions and dosage forms comprising the same
|
US20050196446A1
(en)
*
|
2004-03-05 |
2005-09-08 |
Huang Hai Y. |
Polymeric compositions and dosage forms comprising the same
|
TWI483944B
(zh)
|
2004-03-30 |
2015-05-11 |
Euro Celtique Sa |
含有小於25ppm14-羥可待因酮之羥可酮鹽酸鹽組成物、醫藥劑型、延遲釋出口服劑型及醫藥上可以接受的包裝
|
US20060009425A1
(en)
*
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
WO2005123039A1
(en)
|
2004-06-12 |
2005-12-29 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent drug formulations
|
US7713550B2
(en)
*
|
2004-06-15 |
2010-05-11 |
Andrx Corporation |
Controlled release sodium valproate formulation
|
US20050276848A1
(en)
*
|
2004-06-15 |
2005-12-15 |
Nilobon Podhipleux |
Sustained release neutralized divalproex sodium
|
US20050287185A1
(en)
*
|
2004-06-23 |
2005-12-29 |
David Wong |
Extended release oxybutynin formulation
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
WO2006007354A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
US20050287214A1
(en)
*
|
2004-06-28 |
2005-12-29 |
Ayer Atul D |
Squeeze controlled oral dosage form
|
US8394409B2
(en)
*
|
2004-07-01 |
2013-03-12 |
Intellipharmaceutics Corp. |
Controlled extended drug release technology
|
US20060001011A1
(en)
*
|
2004-07-02 |
2006-01-05 |
Wilson Neil R |
Surface conditioner for powder coating systems
|
CA2576158C
(en)
|
2004-08-05 |
2020-10-27 |
Corium International, Inc. |
Adhesive composition
|
KR20070043894A
(ko)
*
|
2004-08-19 |
2007-04-25 |
알자 코포레이션 |
제어 방출형 나노입자 활성제 제제 제형 및 방법
|
US10624858B2
(en)
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
US20070020330A1
(en)
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
DK2377557T3
(en)
|
2004-11-24 |
2017-02-06 |
Meda Pharmaceuticals Inc |
Compositions comprising azelastine and methods for its use
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
US8252331B2
(en)
*
|
2004-12-03 |
2012-08-28 |
Osmotica Kereskedelmi és Szolgáltató, KFT |
Osmotic device containing amantadine and an osmotic salt
|
US8574626B2
(en)
|
2004-12-03 |
2013-11-05 |
Osmotica Kereskedelmi és Szolgáltató KFT |
Osmotic device containing amantadine and an osmotic salt
|
DE602006003639D1
(de)
*
|
2005-01-27 |
2008-12-24 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
KR20090029856A
(ko)
*
|
2005-01-28 |
2009-03-23 |
유로-셀띠끄 소시에떼 아노님 |
알코올 저항성 제형
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
US7527614B2
(en)
|
2005-03-25 |
2009-05-05 |
Kimberly-Clark Worldwide, Inc. |
Protective tube for a medicated tampon
|
US7744556B2
(en)
*
|
2005-03-25 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Delivery tube assembly for an applicator
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
US7919453B2
(en)
*
|
2005-03-25 |
2011-04-05 |
Kimberly-Clark Worldwide, Inc. |
Dosage cap assembly for an applicator
|
US9295289B2
(en)
*
|
2005-04-01 |
2016-03-29 |
Leslie Jane James |
Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
|
US20080152714A1
(en)
*
|
2005-04-08 |
2008-06-26 |
Yi Gao |
Pharmaceutical Formulations
|
JP5114382B2
(ja)
|
2005-04-08 |
2013-01-09 |
アボット・ラボラトリーズ |
フェノフィブリン酸および/またはそれの塩を含む経口医薬製剤
|
US20060233882A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Sowden Harry S |
Osmotic dosage form
|
EP1874269A2
(en)
*
|
2005-04-19 |
2008-01-09 |
Alza Corporation |
Combination of tramadol and substances that comprise gabapentin
|
US7708726B2
(en)
*
|
2005-04-28 |
2010-05-04 |
Kimberly-Clark Worldwide, Inc. |
Dosage form cap for an applicator
|
EP1896002A4
(en)
|
2005-06-27 |
2009-11-25 |
Biovail Lab Int Srl |
BUPROPIONAL SALT FORMULATIONS WITH MODIFIED RELEASE
|
CN101291652A
(zh)
*
|
2005-06-29 |
2008-10-22 |
阿尔扎公司 |
对渗透剂型提供降低的干燥时间的半渗透性组合物
|
WO2007019393A2
(en)
*
|
2005-08-04 |
2007-02-15 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US20070036929A1
(en)
*
|
2005-08-09 |
2007-02-15 |
The Boeing Company |
Thin film applique
|
CA2620370A1
(en)
*
|
2005-08-30 |
2007-03-22 |
Nicholas Piramal India Limited |
Extended release pharmaceutical composition of metformin and a process for producing it
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
CA2999420A1
(en)
|
2005-09-27 |
2007-04-05 |
Tissuetech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
US20070092559A1
(en)
*
|
2005-10-24 |
2007-04-26 |
Jinghua Yuan |
Liquid dosage forms having enteric properties of delayed and then sustained release
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
MX2008006888A
(es)
|
2005-11-28 |
2008-09-30 |
Marinus Pharmaceuticals |
Formulas y metodos para la manufactura y uso de la ganaxolona.
|
US20070141118A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Damico Joyce A |
Layered dosage form for a medicated tampon assembly
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
WO2007106349A2
(en)
|
2006-03-10 |
2007-09-20 |
Neurogen Corporation |
Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
|
US20190083399A9
(en)
*
|
2006-04-03 |
2019-03-21 |
Isa Odidi |
Drug delivery composition
|
JP5457830B2
(ja)
*
|
2006-04-03 |
2014-04-02 |
オディディ,イサ |
オルガノゾル被膜を含む制御放出送達デバイス
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
US20080090897A1
(en)
|
2006-08-11 |
2008-04-17 |
The Johns Hopkins University |
Compositions and methods for neuroprotectin
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
EP1897543A1
(en)
|
2006-08-30 |
2008-03-12 |
Euro-Celtique S.A. |
Buprenorphine- wafer for drug substitution therapy
|
SI2530083T1
(sl)
|
2006-09-22 |
2016-09-30 |
Pharmacyclics Llc |
Inhibitorji Bruton tirozin kinaze
|
EA201300152A1
(ru)
|
2006-11-27 |
2013-07-30 |
Х. Лундбекк А/С |
Гетероариламидные производные
|
CA2669815A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
WO2008084698A1
(ja)
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
タクロリムス徐放性医薬組成物
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
US8895061B2
(en)
*
|
2007-03-02 |
2014-11-25 |
Meda Pharmaceuticals Inc. |
Compositions comprising carisoprodol and methods of use thereof
|
US20070172525A1
(en)
*
|
2007-03-15 |
2007-07-26 |
Ramesh Sesha |
Anti-diabetic combinations
|
US20080064701A1
(en)
*
|
2007-04-24 |
2008-03-13 |
Ramesh Sesha |
Anti-diabetic combinations
|
AU2008228903B2
(en)
|
2007-03-19 |
2013-03-07 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin B12
|
US20090082315A1
(en)
*
|
2007-09-05 |
2009-03-26 |
Raif Tawakol |
Compositions and Methods for Controlling Cholesterol Levels
|
EP2200607A4
(en)
|
2007-09-10 |
2012-02-22 |
Calcimedica Inc |
COMPOUNDS MODULATING INTRACELLULAR CALCIUM
|
US20090087484A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Alza Corporation |
Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
|
KR101607112B1
(ko)
|
2007-11-23 |
2016-03-29 |
그뤼넨탈 게엠베하 |
타펜타돌 조성물
|
WO2009075782A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
US8551524B2
(en)
*
|
2008-03-14 |
2013-10-08 |
Iycus, Llc |
Anti-diabetic combinations
|
WO2009137631A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that affect expression of cancer-related protein isoforms
|
EP2283160A4
(en)
*
|
2008-05-07 |
2012-01-04 |
Wintherix Llc |
METHOD FOR IDENTIFYING WNT SIGNALING MODULATING COMPOUNDS IN CANCER CELLS
|
AU2008359725A1
(en)
*
|
2008-07-24 |
2010-01-28 |
Handa Pharmaceuticals, Llc |
Stabilized atypical antipsychotic formulation
|
JP5782377B2
(ja)
|
2008-08-27 |
2015-09-24 |
カルシメディカ,インク. |
細胞内カルシウムを調節する化合物
|
US20100190752A1
(en)
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
EP2163240A1
(en)
|
2008-09-12 |
2010-03-17 |
Universita' Degli Studi Di Genova |
A method for the production of bioadhesive compact matrices
|
RU2673882C1
(ru)
|
2008-10-30 |
2018-12-03 |
Грюненталь Гмбх |
Новые и эффективные лекарственные формы тапентадола
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
US20100233259A1
(en)
*
|
2008-12-12 |
2010-09-16 |
Pascal Grenier |
Dosage form of ropinirole
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
CA3045436A1
(en)
|
2009-01-29 |
2010-08-05 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
WO2010090991A1
(en)
*
|
2009-02-04 |
2010-08-12 |
Supernus Pharmaceuticals, Inc. |
Formulations of desvenlafaxine
|
EP3045043B1
(en)
|
2009-02-26 |
2020-04-29 |
Relmada Therapeutics, Inc. |
Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
|
PT2405915T
(pt)
|
2009-03-10 |
2019-01-29 |
Euro Celtique Sa |
Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
|
US9175066B2
(en)
|
2009-04-24 |
2015-11-03 |
Tissuetech, Inc. |
Compositions containing HC-HA complex and methods of use thereof
|
WO2010139111A1
(en)
|
2009-06-02 |
2010-12-09 |
Dow Global Technologies Inc. |
Sustained release dosage form
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US20110238036A1
(en)
*
|
2009-12-23 |
2011-09-29 |
Psivida Us, Inc. |
Sustained release delivery devices
|
WO2011097594A2
(en)
|
2010-02-08 |
2011-08-11 |
Kinagen, Inc. |
Therapeutic methods and compositions involving allosteric kinase inhibition
|
ES2677356T3
(es)
|
2010-03-24 |
2018-08-01 |
Amitech Therapeutics Solutions, Inc. |
Compuestos heterocíclicos útiles para la inhibición de quinasas
|
WO2011122524A1
(ja)
|
2010-03-29 |
2011-10-06 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
CN103491778B
(zh)
|
2010-04-13 |
2017-05-31 |
雷尔玛达治疗股份有限公司 |
1‑甲基‑n‑(2,6‑二甲苯基)‑2‑哌啶甲酰胺的皮肤用药物组合物及其使用方法
|
US20130030237A1
(en)
|
2010-04-15 |
2013-01-31 |
Charles Theuer |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
AU2011248579A1
(en)
|
2010-04-27 |
2012-11-29 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
PL2563776T3
(pl)
|
2010-04-27 |
2017-01-31 |
Calcimedica Inc |
Związki, które modulują wewnątrzkomórkowy wapń
|
US20130259875A1
(en)
|
2010-05-11 |
2013-10-03 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of amyotrophic lateral sclerosis
|
US20120087915A1
(en)
|
2010-06-03 |
2012-04-12 |
Pharmacyclics, Inc. |
Use of inhibitors of bruton's tyrosine kinase (btk)
|
CA2801620A1
(en)
|
2010-07-06 |
2012-01-12 |
Gruenenthal Gmbh |
Novel gastro-retentive dosage forms comprising a gaba analog and an opioid
|
AR082167A1
(es)
|
2010-07-14 |
2012-11-14 |
Gruenenthal Gmbh |
Formas de dosificacion gastrorretentivas
|
PL2600930T3
(pl)
|
2010-08-05 |
2021-09-06 |
Forsight Vision4, Inc. |
Urządzenie wstrzykujące do dostarczania leku
|
RS62540B1
(sr)
|
2010-08-05 |
2021-12-31 |
Forsight Vision4 Inc |
Aparat za lečenje oka
|
CA2807537C
(en)
|
2010-08-05 |
2018-09-18 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
CN103180316A
(zh)
|
2010-08-27 |
2013-06-26 |
钙医学公司 |
调节细胞内钙的化合物
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
MY166034A
(en)
|
2010-12-22 |
2018-05-21 |
Purdue Pharma Lp |
Encased tamper resistant controlled release dosage forms
|
US9233073B2
(en)
|
2010-12-23 |
2016-01-12 |
Purdue Pharma L.P. |
Tamper resistant solid oral dosage forms
|
AU2012204164A1
(en)
|
2011-01-07 |
2013-07-25 |
Allergan, Inc. |
Melanin modification compositions and methods of use
|
US9526770B2
(en)
|
2011-04-28 |
2016-12-27 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
ES2822301T3
(es)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Métodos de procesamiento de tejidos de soporte fetal
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
EP2739252A4
(en)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE
|
EP2755600B1
(en)
|
2011-09-16 |
2021-03-17 |
ForSight Vision4, Inc. |
Fluid exchange apparatus
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
CA2795586A1
(en)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methods and compositions for treatment, modification and management of bone cancer pain
|
CA2800329A1
(en)
|
2011-12-30 |
2013-06-30 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
FR2987264A1
(fr)
|
2012-02-23 |
2013-08-30 |
Golden Biotechnology Corp |
Methodes et compositions pour le traitement des metastases cancereuses
|
CA2867521A1
(en)
|
2012-03-26 |
2013-03-26 |
Golden Biotechnology Corporation |
Methods and compositions for treating arteriosclerotic vascular diseases
|
KR102236805B1
(ko)
|
2012-07-11 |
2021-04-05 |
티슈테크, 인코포레이티드 |
Hc-ha/ptx3 복합체를 함유하는 조성물 및 이의 사용 방법
|
NZ715111A
(en)
|
2012-07-16 |
2016-12-23 |
Rhodes Technologies |
Process for improved opioid synthesis
|
BR112015000944A2
(pt)
|
2012-07-16 |
2019-10-15 |
Rhodes Tech |
processo para síntese melhorada de opioide
|
WO2014059333A1
(en)
|
2012-10-12 |
2014-04-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
CN104968339B
(zh)
|
2012-11-21 |
2019-06-11 |
国鼎生物科技股份有限公司 |
用于治疗神经变性疾病的方法和组合物
|
ES2851175T3
(es)
|
2013-02-05 |
2021-09-03 |
Purdue Pharma Lp |
Formulaciones farmacéuticas resistentes a manipulación
|
TWI597061B
(zh)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
治療白血病之方法及組成物
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US10232018B2
(en)
|
2013-03-14 |
2019-03-19 |
Mallinckrodt Ard Ip Limited |
ACTH for treatment of acute respiratory distress syndrome
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9526654B2
(en)
|
2013-03-28 |
2016-12-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
US9855245B2
(en)
|
2013-04-30 |
2018-01-02 |
Abbvie Inc. |
Methods for improving lipid profiles using atrasentan
|
EP3024461B1
(en)
|
2013-07-23 |
2020-05-13 |
Euro-Celtique S.A. |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
US10098845B2
(en)
|
2013-10-07 |
2018-10-16 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
JP6345786B2
(ja)
|
2013-12-05 |
2018-06-20 |
ファーマサイクリックス エルエルシー |
ブルトン型チロシンキナーゼの阻害剤
|
AU2015207733A1
(en)
|
2014-01-15 |
2016-07-14 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
ES2672795T3
(es)
|
2014-01-15 |
2018-06-18 |
Rhodes Technologies |
Proceso para la síntesis mejorada de oximorfona
|
CN106456595A
(zh)
|
2014-02-10 |
2017-02-22 |
帕塔拉制药有限责任公司 |
用于系统性病症的肥大细胞稳定剂治疗
|
SI3104854T1
(sl)
|
2014-02-10 |
2020-09-30 |
Respivant Sciences Gmbh |
Stabilizatorji mastocitov za zdravljenje pljučnih bolezni
|
WO2015164213A1
(en)
|
2014-04-23 |
2015-10-29 |
The Research Foundation For The State University Of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
TW201603818A
(zh)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
組成物及方法
|
MY182497A
(en)
|
2014-07-15 |
2021-01-25 |
Forsight Vision4 Inc |
Ocular implant delivery device and method
|
EP3177289A4
(en)
|
2014-08-08 |
2018-03-21 |
Forsight Vision4, Inc. |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
WO2016132218A1
(en)
|
2015-02-20 |
2016-08-25 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Method of administering r-baclofen in an extended release dosage form
|
WO2016138025A2
(en)
|
2015-02-23 |
2016-09-01 |
Tissuetech, Inc. |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
WO2016138479A1
(en)
|
2015-02-27 |
2016-09-01 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
EP3061501A1
(en)
|
2015-02-27 |
2016-08-31 |
Rottapharm Ltd. |
Composition for the treatment of acne
|
CA2984443A1
(en)
|
2015-05-20 |
2016-11-24 |
Tissuetech, Inc. |
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
EP3117825A1
(en)
|
2015-07-16 |
2017-01-18 |
Rottapharm S.p.A. |
Oral formulation comprising berberine and morus alba extract
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
CA2996177A1
(en)
|
2015-08-31 |
2017-03-09 |
Pharmacyclics Llc |
Btk inhibitor combinations for treating multiple myeloma
|
CN108430405B
(zh)
|
2015-11-20 |
2021-04-13 |
弗赛特影像4股份有限公司 |
用于缓释药物递送装置的多孔结构
|
TW201733600A
(zh)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
胎兒扶持組織物及使用方法
|
WO2017147146A1
(en)
|
2016-02-23 |
2017-08-31 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists
|
CA3019822A1
(en)
|
2016-04-05 |
2017-10-12 |
Forsight Vision4, Inc. |
Implantable ocular drug delivery devices
|
US11883381B2
(en)
|
2016-05-12 |
2024-01-30 |
The Regents Of The University Of Michigan |
ASH1L inhibitors and methods of treatment therewith
|
US10821105B2
(en)
|
2016-05-25 |
2020-11-03 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
CN106317468A
(zh)
*
|
2016-08-23 |
2017-01-11 |
无锡市永亿精密铸造有限公司 |
一种用于超声波美容仪的复合材料
|
EA201990508A1
(ru)
|
2016-08-26 |
2019-09-30 |
Куртана Фармасьютикалс, Инк. |
ИНГИБИРОВАНИЕ АКТИВНОСТИ Olig2
|
JP2019528320A
(ja)
|
2016-08-31 |
2019-10-10 |
レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングRespivant Sciences Gmbh |
特発性肺線維症による慢性咳の治療のためのクロモリン組成物
|
US10736905B1
(en)
|
2016-09-09 |
2020-08-11 |
Shahin Fatholahi |
Nefopam dosage forms and methods of treatment
|
CN109803724A
(zh)
|
2016-10-07 |
2019-05-24 |
瑞思皮万特科学有限责任公司 |
用于治疗肺纤维化的色甘酸组合物
|
US11446311B2
(en)
|
2017-09-08 |
2022-09-20 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
US10736874B1
(en)
|
2017-09-08 |
2020-08-11 |
Shahin Fatholahi |
Methods for treating pain associated with sickle cell disease
|
JP2021502388A
(ja)
|
2017-11-10 |
2021-01-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Ash1l阻害剤及びそれを用いた治療方法
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン4・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
EP3720439A4
(en)
|
2017-12-07 |
2021-09-08 |
The Regents Of The University Of Michigan |
NSD FAMILY INHIBITORS AND TREATMENT METHODS INCLUDING THESE
|
US20190247331A1
(en)
|
2018-02-15 |
2019-08-15 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US10213394B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Felelõsségû Társaság |
Composition and method for treating neurological disease
|
US10213393B1
(en)
|
2018-02-15 |
2019-02-26 |
Osmotica Kereskedelmi és Szolgáltató Korlátolt Feleõsségû Társaság |
Composition and method for treating neurological disease
|
JP2021513987A
(ja)
|
2018-02-16 |
2021-06-03 |
エスペリオン・セラピューティクス・インコーポレイテッドEsperion Therapeutics, Inc. |
ベンペド酸の持続放出製剤
|
WO2019169112A1
(en)
|
2018-02-28 |
2019-09-06 |
Curtana Pharmaceuticals, Inc. |
Inhibition of olig2 activity
|
JP2021527064A
(ja)
|
2018-06-07 |
2021-10-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
Prc1阻害剤及びそれを用いた治療方法
|
TW202019887A
(zh)
|
2018-07-27 |
2020-06-01 |
美商同心止痛劑股份有限公司 |
酚系trpv1促效劑之聚乙二醇化前藥
|
WO2020142557A1
(en)
|
2018-12-31 |
2020-07-09 |
Biomea Fusion, Llc |
Irreversible inhibitors of menin-mll interaction
|
SG11202109899VA
(en)
|
2019-03-15 |
2021-10-28 |
Unicycive Therapeutics Inc |
Nicorandil derivatives
|
CA3185209A1
(en)
|
2020-07-10 |
2021-01-27 |
Alyssa WINKLER |
Gas41 inhibitors and methods of use thereof
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
US11986449B2
(en)
|
2020-12-22 |
2024-05-21 |
Amneal Pharmaceuticals Llc |
Levodopa dosing regimen
|
TW202320796A
(zh)
|
2021-08-11 |
2023-06-01 |
美商拜歐米富士恩股份有限公司 |
用於糖尿病的menin-mll相互作用之共價抑制劑
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
TW202340177A
(zh)
|
2021-12-30 |
2023-10-16 |
美商拜歐米富士恩股份有限公司 |
作為 flt3抑制劑之吡嗪化合物
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|